Report Detail

Medical Devices & Consumables Global and United States COVID-19 Rapid Antigen Test Kits Market Report & Forecast 2022-2028

  • RnM4421542
  • |
  • 11 April, 2022
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Summary:

The COVID-19 Rapid Antigen Test Kit is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in nasopharyngeal swab, nasal swab and oropharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider .
Market Analysis and Insights: Global and United States COVID-19 Rapid Antigen Test Kits Market
This report focuses on global and United States COVID-19 Rapid Antigen Test Kits market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global COVID-19 Rapid Antigen Test Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasopharyngeal Swab accounting for % of the COVID-19 Rapid Antigen Test Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the COVID-19 Rapid Antigen Test Kits market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global COVID-19 Rapid Antigen Test Kits Scope and Market Size
COVID-19 Rapid Antigen Test Kits market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global COVID-19 Rapid Antigen Test Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the COVID-19 Rapid Antigen Test Kits market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the COVID-19 Rapid Antigen Test Kits market is segmented into
Nasopharyngeal Swab
Nasal Swab
Oropharyngeal Swab
Saliva Swab
Segment by Application, the COVID-19 Rapid Antigen Test Kits market is segmented into
Hospital
Company
School
Home
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and COVID-19 Rapid Antigen Test Kits Market Share Analysis
COVID-19 Rapid Antigen Test Kits market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in COVID-19 Rapid Antigen Test Kits business, the date to enter into the COVID-19 Rapid Antigen Test Kits market, COVID-19 Rapid Antigen Test Kits product introduction, recent developments, etc.
The major vendors covered:
Abbott
AESKU.GROUP
ARISTA® Biotech
IHealth
Quidel
ACCESS BIO
ROCHE DIAGNOSTICS
Artron Laboratories
Philosys
Innovation Scientific
CTK Biotech
GenBody Inc
SD Biosensor
JOYSBIO
Medriva
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)


Table of Contents

    1 Study Coverage

    • 1.1 COVID-19 Rapid Antigen Test Kits Product Introduction
    • 1.2 Global COVID-19 Rapid Antigen Test Kits Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global COVID-19 Rapid Antigen Test Kits Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global COVID-19 Rapid Antigen Test Kits Sales in Volume for the Year 2017-2028
    • 1.3 United States COVID-19 Rapid Antigen Test Kits Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States COVID-19 Rapid Antigen Test Kits Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States COVID-19 Rapid Antigen Test Kits Sales in Volume for the Year 2017-2028
    • 1.4 COVID-19 Rapid Antigen Test Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States COVID-19 Rapid Antigen Test Kits in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of COVID-19 Rapid Antigen Test Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 COVID-19 Rapid Antigen Test Kits Market Dynamics
      • 1.5.1 COVID-19 Rapid Antigen Test Kits Industry Trends
      • 1.5.2 COVID-19 Rapid Antigen Test Kits Market Drivers
      • 1.5.3 COVID-19 Rapid Antigen Test Kits Market Challenges
      • 1.5.4 COVID-19 Rapid Antigen Test Kits Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 COVID-19 Rapid Antigen Test Kits Market Segment by Type
      • 2.1.1 Nasopharyngeal Swab
      • 2.1.2 Nasal Swab
      • 2.1.3 Oropharyngeal Swab
      • 2.1.4 Saliva Swab
    • 2.2 Global COVID-19 Rapid Antigen Test Kits Market Size by Type
      • 2.2.1 Global COVID-19 Rapid Antigen Test Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global COVID-19 Rapid Antigen Test Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global COVID-19 Rapid Antigen Test Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States COVID-19 Rapid Antigen Test Kits Market Size by Type
      • 2.3.1 United States COVID-19 Rapid Antigen Test Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States COVID-19 Rapid Antigen Test Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States COVID-19 Rapid Antigen Test Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 COVID-19 Rapid Antigen Test Kits Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Company
      • 3.1.3 School
      • 3.1.4 Home
      • 3.1.5 Others
    • 3.2 Global COVID-19 Rapid Antigen Test Kits Market Size by Application
      • 3.2.1 Global COVID-19 Rapid Antigen Test Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global COVID-19 Rapid Antigen Test Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global COVID-19 Rapid Antigen Test Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States COVID-19 Rapid Antigen Test Kits Market Size by Application
      • 3.3.1 United States COVID-19 Rapid Antigen Test Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States COVID-19 Rapid Antigen Test Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States COVID-19 Rapid Antigen Test Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global COVID-19 Rapid Antigen Test Kits Competitor Landscape by Company

    • 4.1 Global COVID-19 Rapid Antigen Test Kits Market Size by Company
      • 4.1.1 Top Global COVID-19 Rapid Antigen Test Kits Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global COVID-19 Rapid Antigen Test Kits Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global COVID-19 Rapid Antigen Test Kits Sales by Manufacturer (2017-2022)
      • 4.1.4 Global COVID-19 Rapid Antigen Test Kits Price by Manufacturer (2017-2022)
    • 4.2 Global COVID-19 Rapid Antigen Test Kits Concentration Ratio (CR)
      • 4.2.1 COVID-19 Rapid Antigen Test Kits Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of COVID-19 Rapid Antigen Test Kits in 2021
      • 4.2.3 Global COVID-19 Rapid Antigen Test Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global COVID-19 Rapid Antigen Test Kits Manufacturing Base Distribution, Product Type
      • 4.3.1 Global COVID-19 Rapid Antigen Test Kits Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers COVID-19 Rapid Antigen Test Kits Product Type
      • 4.3.3 Date of International Manufacturers Enter into COVID-19 Rapid Antigen Test Kits Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States COVID-19 Rapid Antigen Test Kits Market Size by Company
      • 4.5.1 Top COVID-19 Rapid Antigen Test Kits Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States COVID-19 Rapid Antigen Test Kits Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States COVID-19 Rapid Antigen Test Kits Sales by Players (2020, 2021 & 2022)

    5 Global COVID-19 Rapid Antigen Test Kits Market Size by Region

    • 5.1 Global COVID-19 Rapid Antigen Test Kits Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global COVID-19 Rapid Antigen Test Kits Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global COVID-19 Rapid Antigen Test Kits Sales in Volume by Region: 2017-2022
      • 5.2.2 Global COVID-19 Rapid Antigen Test Kits Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global COVID-19 Rapid Antigen Test Kits Market Size in Value by Region (2017-2028)
      • 5.3.1 Global COVID-19 Rapid Antigen Test Kits Sales in Value by Region: 2017-2022
      • 5.3.2 Global COVID-19 Rapid Antigen Test Kits Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America COVID-19 Rapid Antigen Test Kits Market Size YoY Growth 2017-2028
      • 6.1.2 North America COVID-19 Rapid Antigen Test Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific COVID-19 Rapid Antigen Test Kits Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific COVID-19 Rapid Antigen Test Kits Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe COVID-19 Rapid Antigen Test Kits Market Size YoY Growth 2017-2028
      • 6.3.2 Europe COVID-19 Rapid Antigen Test Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America COVID-19 Rapid Antigen Test Kits Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America COVID-19 Rapid Antigen Test Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa COVID-19 Rapid Antigen Test Kits Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa COVID-19 Rapid Antigen Test Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Abbott
      • 7.1.1 Abbott Corporation Information
      • 7.1.2 Abbott Description and Business Overview
      • 7.1.3 Abbott COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Abbott COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.1.5 Abbott Recent Development
    • 7.2 AESKU.GROUP
      • 7.2.1 AESKU.GROUP Corporation Information
      • 7.2.2 AESKU.GROUP Description and Business Overview
      • 7.2.3 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.2.5 AESKU.GROUP Recent Development
    • 7.3 ARISTA® Biotech
      • 7.3.1 ARISTA® Biotech Corporation Information
      • 7.3.2 ARISTA® Biotech Description and Business Overview
      • 7.3.3 ARISTA® Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 ARISTA® Biotech COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.3.5 ARISTA® Biotech Recent Development
    • 7.4 IHealth
      • 7.4.1 IHealth Corporation Information
      • 7.4.2 IHealth Description and Business Overview
      • 7.4.3 IHealth COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 IHealth COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.4.5 IHealth Recent Development
    • 7.5 Quidel
      • 7.5.1 Quidel Corporation Information
      • 7.5.2 Quidel Description and Business Overview
      • 7.5.3 Quidel COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Quidel COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.5.5 Quidel Recent Development
    • 7.6 ACCESS BIO
      • 7.6.1 ACCESS BIO Corporation Information
      • 7.6.2 ACCESS BIO Description and Business Overview
      • 7.6.3 ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 ACCESS BIO COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.6.5 ACCESS BIO Recent Development
    • 7.7 ROCHE DIAGNOSTICS
      • 7.7.1 ROCHE DIAGNOSTICS Corporation Information
      • 7.7.2 ROCHE DIAGNOSTICS Description and Business Overview
      • 7.7.3 ROCHE DIAGNOSTICS COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 ROCHE DIAGNOSTICS COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.7.5 ROCHE DIAGNOSTICS Recent Development
    • 7.8 Artron Laboratories
      • 7.8.1 Artron Laboratories Corporation Information
      • 7.8.2 Artron Laboratories Description and Business Overview
      • 7.8.3 Artron Laboratories COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Artron Laboratories COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.8.5 Artron Laboratories Recent Development
    • 7.9 Philosys
      • 7.9.1 Philosys Corporation Information
      • 7.9.2 Philosys Description and Business Overview
      • 7.9.3 Philosys COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Philosys COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.9.5 Philosys Recent Development
    • 7.10 Innovation Scientific
      • 7.10.1 Innovation Scientific Corporation Information
      • 7.10.2 Innovation Scientific Description and Business Overview
      • 7.10.3 Innovation Scientific COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Innovation Scientific COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.10.5 Innovation Scientific Recent Development
    • 7.11 CTK Biotech
      • 7.11.1 CTK Biotech Corporation Information
      • 7.11.2 CTK Biotech Description and Business Overview
      • 7.11.3 CTK Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 CTK Biotech COVID-19 Rapid Antigen Test Kits Products Offered
      • 7.11.5 CTK Biotech Recent Development
    • 7.12 GenBody Inc
      • 7.12.1 GenBody Inc Corporation Information
      • 7.12.2 GenBody Inc Description and Business Overview
      • 7.12.3 GenBody Inc COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 GenBody Inc Products Offered
      • 7.12.5 GenBody Inc Recent Development
    • 7.13 SD Biosensor
      • 7.13.1 SD Biosensor Corporation Information
      • 7.13.2 SD Biosensor Description and Business Overview
      • 7.13.3 SD Biosensor COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 SD Biosensor Products Offered
      • 7.13.5 SD Biosensor Recent Development
    • 7.14 JOYSBIO
      • 7.14.1 JOYSBIO Corporation Information
      • 7.14.2 JOYSBIO Description and Business Overview
      • 7.14.3 JOYSBIO COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 JOYSBIO Products Offered
      • 7.14.5 JOYSBIO Recent Development
    • 7.15 Medriva
      • 7.15.1 Medriva Corporation Information
      • 7.15.2 Medriva Description and Business Overview
      • 7.15.3 Medriva COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Medriva Products Offered
      • 7.15.5 Medriva Recent Development
    • 7.16 AUISET
      • 7.16.1 AUISET Corporation Information
      • 7.16.2 AUISET Description and Business Overview
      • 7.16.3 AUISET COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 AUISET Products Offered
      • 7.16.5 AUISET Recent Development
    • 7.17 Biotest Biotech
      • 7.17.1 Biotest Biotech Corporation Information
      • 7.17.2 Biotest Biotech Description and Business Overview
      • 7.17.3 Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Biotest Biotech Products Offered
      • 7.17.5 Biotest Biotech Recent Development
    • 7.18 Hangzhou AllTest Biotech
      • 7.18.1 Hangzhou AllTest Biotech Corporation Information
      • 7.18.2 Hangzhou AllTest Biotech Description and Business Overview
      • 7.18.3 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.18.4 Hangzhou AllTest Biotech Products Offered
      • 7.18.5 Hangzhou AllTest Biotech Recent Development
    • 7.19 ACON Biotech
      • 7.19.1 ACON Biotech Corporation Information
      • 7.19.2 ACON Biotech Description and Business Overview
      • 7.19.3 ACON Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.19.4 ACON Biotech Products Offered
      • 7.19.5 ACON Biotech Recent Development
    • 7.20 Lepu Medical Technology
      • 7.20.1 Lepu Medical Technology Corporation Information
      • 7.20.2 Lepu Medical Technology Description and Business Overview
      • 7.20.3 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.20.4 Lepu Medical Technology Products Offered
      • 7.20.5 Lepu Medical Technology Recent Development
    • 7.21 BGI
      • 7.21.1 BGI Corporation Information
      • 7.21.2 BGI Description and Business Overview
      • 7.21.3 BGI COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.21.4 BGI Products Offered
      • 7.21.5 BGI Recent Development
    • 7.22 Phase Scientific
      • 7.22.1 Phase Scientific Corporation Information
      • 7.22.2 Phase Scientific Description and Business Overview
      • 7.22.3 Phase Scientific COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.22.4 Phase Scientific Products Offered
      • 7.22.5 Phase Scientific Recent Development
    • 7.23 Assure Tech
      • 7.23.1 Assure Tech Corporation Information
      • 7.23.2 Assure Tech Description and Business Overview
      • 7.23.3 Assure Tech COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.23.4 Assure Tech Products Offered
      • 7.23.5 Assure Tech Recent Development
    • 7.24 BIOHIT Healthcare (Hefei)
      • 7.24.1 BIOHIT Healthcare (Hefei) Corporation Information
      • 7.24.2 BIOHIT Healthcare (Hefei) Description and Business Overview
      • 7.24.3 BIOHIT Healthcare (Hefei) COVID-19 Rapid Antigen Test Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.24.4 BIOHIT Healthcare (Hefei) Products Offered
      • 7.24.5 BIOHIT Healthcare (Hefei) Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 COVID-19 Rapid Antigen Test Kits Industry Chain Analysis
    • 8.2 COVID-19 Rapid Antigen Test Kits Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 COVID-19 Rapid Antigen Test Kits Distributors
    • 8.3 COVID-19 Rapid Antigen Test Kits Production Mode & Process
    • 8.4 COVID-19 Rapid Antigen Test Kits Sales and Marketing
      • 8.4.1 COVID-19 Rapid Antigen Test Kits Sales Channels
      • 8.4.2 COVID-19 Rapid Antigen Test Kits Distributors
    • 8.5 COVID-19 Rapid Antigen Test Kits Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on COVID-19 Rapid Antigen Test Kits. Industry analysis & Market Report on COVID-19 Rapid Antigen Test Kits is a syndicated market report, published as Global and United States COVID-19 Rapid Antigen Test Kits Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of COVID-19 Rapid Antigen Test Kits market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,076.15
      6,152.30
      3,592.05
      7,184.10
      598,867.50
      1,197,735.00
      320,820.50
      641,641.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report